Stomach Cancer

Colorectal cancer and stomach cancer are two gastrointestinal cancers whose origins are most probably influenced by the intestinal microbiota.

Created 03 August 2021
Updated 17 July 2024
stomach cancer

About this article

Created 03 August 2021
Updated 17 July 2024

Colorectal cancer, the importance of environmental factors 

With 694,000 deaths per year around the world, colorectal cancer is the 2nd most deadly cancer. Genetic factors are a significant but minority cause of gastrointestinal cancer, which is most heavily attributed to environmental factors such as sedentary lifestyle, obesity, and, in particular unbalanced diet, which causes intestinal dysbiosis. Furthermore, the hypothesis of an imbalance between harmful and beneficial bacterial species with regard to this cancer is more than likely.

Colorectal cancer doesn’t show any symptoms for a long time, then manifests by persistent or sudden problems with intestinal transit: constipation, diarrhea, the pressing need to go, etc. 

Examining the stool for blood and colonoscopy are the two primary methods for detecting colorectal cancer.

Surgery forms the basis of treatment via the removal of part of the colon, sometimes supplemented with chemotherapy or radiation therapy. 

Bacteria responsible for 80% of stomach cancers

Although various risk factors have been identified (smoking, diet, family history, genetic predisposition), the primary cause of stomach cancer is Helicobacter pylori a pathogenic bacteria that causes chronic gastritis.

The symptoms are not very specific: stomach pain repeated nausea and vomiting, and a change in general state. Only endoscopy of the stomach and esophagus can confirm the diagnosis.

Surgery is the reference treatment for localized tumors, with partial or total removal of the stomach. For locally advanced forms, physicians also add chemotherapy.

Restoring the microbiota, therapy of the future?

Since the existence of a connection between bacteria and gastrointestinal cancers seems more than likely, manipulating the microbiota with probiotics and prebiotics is being studied as a potential therapeutic treatment.  


World Cancer Research Fund International, Colorectal cancer statistics

GLOBOCAN project, Colorectal Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 

InCA. Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. InCA, 2013.

Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014 ; 10 : 766.

Le cancer de l'estomac : points clés. Institut national du cancer.

Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, et al. Microbial Dysbiosis in Colorectal Cancer (CRC) Patients. PLOS ONE 2011 ; 6(1): e16393.

Wang LL, Yu XJ, Zhan SH, Jia SJ, et al. Participation of microbiota in the development of gastric cancer. World Journal of Gastroenterology : WJG. 2014 ; 20(17):4948-4952.

Mehta RS, Nishihara R, Cao Y, et al. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue [published correction appears in JAMA Oncol. 2019 Apr 1;5(4):579]. JAMA Oncol. 2017;3(7):921-927.

Microbiote intestinal et santé. Inserm, février 2016.

Sobhani I, Amiot A, Le Baleur Y, et al. Microbial dysbioses and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther Adv Gastroenterol 2013 ; 6 : 215-29.